These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8102212

  • 1. Lack of promotion of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in mice by rat cancer promoters.
    Tamano S, Asakawa E, Boomyaphiphat P, Masui T, Fukushima S.
    Teratog Carcinog Mutagen; 1993; 13(2):89-96. PubMed ID: 8102212
    [Abstract] [Full Text] [Related]

  • 2. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
    Ito N, Fukushima S, Shirai T, Hagiwara A, Imaida K.
    IARC Sci Publ; 1984; (56):399-407. PubMed ID: 6536604
    [Abstract] [Full Text] [Related]

  • 3. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL, Shirai T, Kato T, Asamoto M, Fukushima S.
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [Abstract] [Full Text] [Related]

  • 4. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
    Chen TX, Wanibuchi H, Murai T, Kitano M, Yamamoto S, Fukushima S.
    Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
    [Abstract] [Full Text] [Related]

  • 5. Lack of promotion of urinary bladder carcinogenesis by sodium bicarbonate and/or L-ascorbic acid in male ODS/Shi-od/od rats synthesizing alpha 2 mu-globulin but not L-ascorbic acid.
    Mori S, Murai T, Hosono M, Machino S, Makino S, Chou C, Fukushima S.
    Food Chem Toxicol; 1997 Aug; 35(8):783-7. PubMed ID: 9350223
    [Abstract] [Full Text] [Related]

  • 6. F344/Shi rats bearing type b catalase-1 locus are sensitive to sodium L-ascorbate promotion of two-stage urinary bladder carcinogenesis.
    Mori S, Murai T, Hosono M, Yamashita H, Oohara T, Makino S, Doteuchi M, Fukushima S.
    Teratog Carcinog Mutagen; 1998 Aug; 18(1):27-33. PubMed ID: 9586768
    [Abstract] [Full Text] [Related]

  • 7. Concentration dependent promoting effects of sodium L-ascorbate with the same total dose in a rat two-stage urinary bladder carcinogenesis.
    Chen TX, Wanibuchi H, Wei M, Morimura K, Yamamoto S, Hayashi S, Fukushima S.
    Cancer Lett; 1999 Nov 01; 146(1):67-71. PubMed ID: 10656611
    [Abstract] [Full Text] [Related]

  • 8. Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model.
    Shibata MA, Hasegawa R, Shirai T, Takesada Y, Fukushima S.
    Int J Cancer; 1993 Dec 02; 55(6):1011-7. PubMed ID: 8253519
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Summation and synergism in the promotion of urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine in F344 rats.
    Sakata T, Shirai T, Fukushima S, Hasegawa R, Ito N.
    Gan; 1984 Nov 02; 75(11):950-6. PubMed ID: 6519396
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI, Wanibuchi H, Morimura K, Kim S, Yano Y, Yamamoto S, Fukushima S.
    Carcinogenesis; 2000 Feb 02; 21(2):195-203. PubMed ID: 10657958
    [Abstract] [Full Text] [Related]

  • 14. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T, Na Y, Wanibuchi H, Yamamoto S, Lee CC, Fukushima S.
    Jpn J Cancer Res; 1999 Aug 02; 90(8):818-23. PubMed ID: 10543252
    [Abstract] [Full Text] [Related]

  • 15. No promotion of urinary bladder carcinogenesis by sodium L-ascorbate in male ODS/Shi-od/od rats lacking L-ascorbic acid-synthesizing ability.
    Mori S, Murai T, Takeuchi Y, Hosono M, Ohhara T, Makino S, Hayashi Y, Shibata MA, Kurata Y, Hagiwara A.
    Carcinogenesis; 1991 Oct 02; 12(10):1869-73. PubMed ID: 1934267
    [Abstract] [Full Text] [Related]

  • 16. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Fukushima S, Ogiso T, Kurata Y, Hirose M, Ito N.
    Cancer Lett; 1987 Jan 02; 34(1):83-90. PubMed ID: 3802071
    [Abstract] [Full Text] [Related]

  • 17. Modification of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in rats by phytic acid and its salts.
    Takaba K, Hirose M, Ogawa K, Hakoi K, Fukushima S.
    Food Chem Toxicol; 1994 Jun 02; 32(6):499-503. PubMed ID: 8045454
    [Abstract] [Full Text] [Related]

  • 18. Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate.
    Takaba K, Saeki K, Suzuki K, Wanibuchi H, Fukushima S.
    Carcinogenesis; 2000 Apr 02; 21(4):691-700. PubMed ID: 10753205
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.